Transluminal Technologies

OverviewSuggest Edit

Transluminal Technologies is a company engaged in the development of interventional cardiology devices. It offers Velox CD, a bioabsorbable magnesium alloy closure device, and Velox LB, a vascular closure device for large-bore percutaneous procedures.
TypePrivate
Founded2008
HQSyracuse, NY, US
Websitetransluminal.net

Locations

Transluminal Technologies is headquartered in
Syracuse, United States

Location Map

Latest Updates

Cybersecurity ratingAMore

Transluminal Technologies Office Locations

Transluminal Technologies has an office in Syracuse
Syracuse, NY, US (HQ)
2930 E Genesee St
Show all (1)

Transluminal Technologies Financials and Metrics

Summary Metrics

Founding Date

2008

Transluminal Technologies total Funding

$1.5 m

Transluminal Technologies latest funding size

$1.50 m

Time since last funding

6 years ago
Transluminal Technologies's latest funding round in May 2015 was reported to be $1.5 m. In total, Transluminal Technologies has raised $1.5 m
Show all financial metrics

Transluminal Technologies Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Transluminal Technologies Online and Social Media Presence

Embed Graph

Transluminal Technologies Frequently Asked Questions

  • When was Transluminal Technologies founded?

    Transluminal Technologies was founded in 2008.

  • Who are Transluminal Technologies competitors?

    Competitors of Transluminal Technologies include Medartis Holding, SeaSpine and USGI Medical.

  • Where is Transluminal Technologies headquarters?

    Transluminal Technologies headquarters is located at 2930 E Genesee St, Syracuse.

  • Where are Transluminal Technologies offices?

    Transluminal Technologies has an office in Syracuse.

  • How many offices does Transluminal Technologies have?

    Transluminal Technologies has 1 office.